Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
This study introduces a pivotal model that aids physicians in making informed decisions regarding bone marrow sampling for MGUS patients, utilizing a comprehensive set of biomarkers to predict the progression to SMM or worse conditions with high accuracy.
Hematology/Oncology April 8th 2024
OBR Oncology
Explore this development in metastatic melanoma treatment with the FDA’s accelerated approval of TIL therapy, a promising approach for patients who have exhausted other options.
The Epoch Times
The recent uncovering of KSHV’s method of commandeering cell metabolism for cancer progression not only highlights a novel therapeutic target but also emphasizes the need for vigilant monitoring in immunocompromised patients, where such viral activations are more likely to precipitate aggressive cancers.
Imetelstat has shown promising results in improving the quality of life for MDS patients by significantly reducing transfusion dependency, a critical consideration in the management of this blood disorder.
Healthgrades for Professionals
Explore key points for patient communication on chemotherapy, offering a clear framework to discuss treatment goals, processes, and side effects, enhancing patient understanding and engagement in their care journey.
Hematology/Oncology April 1st 2024
MDLinx
A radiologist’s failure to detect early-stage cancer exemplifies the profound implications of diagnostic accuracy in radiology, emphasizing the necessity for vigilance in interpreting imaging studies to prevent catastrophic outcomes.